Pharmacists in Larose, LA Accepting Medicare
6 Pharmacists found. Showing 1 - 6
 Trang Tran Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 13998 W Main St, Larose, LA 70373 Phone: 985-693-8662 |
 Harold Walker Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 13086 Highway 3235, Larose, LA 70373 Phone: 985-693-9260 Fax: 985-693-9265 |
Sabrina Hagar Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 13998 W Main Street, Larose, LA 70373 Phone: 985-693-8662 |
Desirae Elizabeth Barrios, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 13998 W Main St, Larose, LA 70373 Phone: 985-693-8662 |
Elmo Charles Gautreaux, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 13998 W Main St, Larose, LA 70373 Phone: 985-693-8662 Fax: 985-693-8867 |
Mr. Blake P Pitre Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 13087 West Main St, Larose, LA 70363 Phone: 985-693-7496 Fax: 985-798-7997 |
News Archive
High BMI leads to epigenetic changes, study shows
The extra pounds you gain during the holidays will not only show up on your hips but will also affect your DNA.
Auxilium doses first patient in CCH Phase 2b study for treatment frozen shoulder syndrome
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX in the U.S. and XIAPEX in the EU, today announced that its partner Auxilium Pharmaceuticals, Inc. has dosed the first patient in its Phase 2b study of collagenase clostridium histolyticum for the treatment of frozen shoulder syndrome (adhesive capsulitis).
Blog reports on meeting of world's largest HIV vaccine research network
KPLU 88.5's "Humanosphere" blog reports on a meeting of the HIV Vaccine Trials Network (HVTN), "the world's largest HIV vaccine research network," held in Seattle this week. "We actually don't know what the agenda is," HVTN Executive Director Jim Kublin said during a lecture, titled "Scientific Agenda, the Next Seven Years," according to the blog.
BDSI enrolls first patient in Clonidine Topical Gel Phase 3 trial for treatment of painful diabetic neuropathy
BioDelivery Sciences International, Inc. announced today the enrollment of the first patient in the RHAPSODY Study, a Phase 3 clinical trial of Clonidine Topical Gel for the treatment of painful diabetic neuropathy.
› Verified 5 days ago